27
)84(1 0 +% *+ & - -% 6!# !#$ !$ !0 ')H L 2@ 1 FD ! / 2 . " 7 I ' 2D ) " 4 ' # # " 37*)(16 Q ) # > 3'7/)/6 Q 1 " 374'.16 Q / " 37*)(16 Q . # 2 " 37*''.6 Q 7 G " Q 4 > 3'7/)/6 &'!()# # & A 0 32"6 + >0 & 0 > +- R D >0 0 + - & L 9 /1& A 0>0 + - ') >0 A 3 E ')6Q 1' A 3 E '..6+ - @ )* 3@&)*6 # A 0 *+./ *+() + ! $ ).4 '(5 3/8:).46 > >0 1(5 3'*':).46 0> 3'*':).46+ 0 0 >0 3).:7'6 0> 3/7:7'6 0+ 0 0 0 '45 3'*:.(6 '.5 3/:)46 85 3.:7.6 15 3):7'6 0+ ! @0 R > + , 0 D + ! 2 >0 0 0+ - 0 + 0 & A 0 + *$+ 0

0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 2: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

"The New Normal of Medica l Care and Educat ion in

Resource-L imited Sett ings : COVID-19 Pandemic and

Beyond"

Page 3: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

T h e n o v e l c o r o n a v i r u s d i s e a s e 2 0 1 9 ( C O V I D - 1 9 ) b e g a n i n C h i n a i nD e c e m b e r 2 0 1 9 a n d c o n t i n u e s a f f e c t i n g m i l l i o n s o f p e o p l e a r o u n d t h ew o r l d . N o w , i t h a s g a i n e d t h e s t a t u s o f a p a n d e m i c , r e a c h i n g 1 2 . 3m i l l i o n c a s e s g l o b a l l y , a n d 1 3 , 4 8 8 c a s e s i n I n d o n e s i a a l o n e a s t h i sf o r e w o r d i s w r i t t e n , s i x m o n t h s a f t e r t h e d i s e a s e b e g a n t o s p r e a d . T h eh e a l t h c a r e s y s t e m i s o n l y a p a r t t h a t i s b e i n g a f f e c t e d b y t h e C O V I D -1 9 p a n d e m i c . I t h a s c r e a t e d c h a n g e s i n e v e r y a s p e c t o f o u r l i v e s s u c ha s s o c i a l a n d e c o n o m i c s s i t u a t i o n . T h e I n d o n e s i a n g o v e r n m e n t h a sc r e a t e d t h e t e r m “ N e w N o r m a l ” t o d e s c r i b e t h i s e r a ; t h e t i m e i n w h i c hw e c o n t i n u o u s l y b a t t l e t h e p a n d e m i c w h i l e r e s u m i n g o u r p r e v i o u sa c t i v i t i e s . D e s p i t e b e i n g i n t h e “ N e w N o r m a l ” e r a , t h e s t r u g g l e i nm a n a g i n g t h i s d i s e a s e b e c o m e s e v e n m o r e d i f f i c u l t , e s p e c i a l l y i n ad e v e l o p i n g c o u n t r y t h a t c o m p r i s e s t h o u s a n d s o f i s l a n d s s u c h a sI n d o n e s i a . W h i l e i n t e r n a t i o n a l s t u d i e s a r e b e i n g c o n d u c t e d , w e n e e da l s o t o t h i n k a b o u t h o w t o e x p a n d o u r m e a s u r e s t o t h e s e a r e a s , b e i tw i t h a n e w a p p r o a c h o r l e s s e r - k n o w n , e x i s t i n g o n e . W e d o n o t o n l yn e e d i n n o v a t i o n s i n t r e a t m e n t a n d v a c c i n e s , b u t a l s o i n o t h e r a s p e c t ss u c h a s d i a g n o s i s , u n d e r s t a n d i n g o f m e c h a n i s m , a n d p o l i c y - m a k i n g . T h eF a c u l y o f M e d i c i n e U n i v e r s i t a s I n d o n e s i a , i n a c c o r d a n c e w i t h d r . C i p t oM a n g u n k u s u m o N a t i o n a l G e n e r a l H o s p i t a l , U n i v e r s i t a s I n d o n e s i aA c a d e m i c H e a l t h S y s t e m ( A H S ) a n d I n d o n e s i a n I n n o v a t i o n f o r H e a l t h( I N N O V A T E ) , b r i n g s t h i s i s s u e i n t h e 5 t h I n t e r n a t i o n a l C o n f e r e n c e a n dE x h i b i t i o n o n t h e I n d o n e s i a n M e d i c a l E d u c a t i o n a n d R e s e a r c h I n s t i t u t e( I C E o n I M E R I ) . T h e 5 t h I C E o n I M E R I w i l l b e a v i r t u a l e v e n t t h a tb r i n g s t o g e t h e r a m u l t i - d i s c i p l i n a r y g r o u p o f v a r i o u s p r o f e s s i o n s s u c ha s a c a d e m i c i a n s , p o l i c y m a k e r s , r e s e a r c h e r s , c l i n i c i a n s , e n g i n e e r s , o ra n y o t h e r p r o f e s s i o n s t o p r e s e n t a n d e x c h a n g e i d e a s r e g a r d i n gr e s e a r c h i n t h e t i m e o f C O V I D - 1 9 p a n d e m i c . W h i l e t h e p r o g r a mc o m p r i s e s m a i n s y m p o s i u m , t h e r e a r e p r e - a n d p o s t - c o n g r e s s w o r k s ho p t h a t t h e a t t e n d e e s c a n j o i n . W i t h “ T h e ‘ N e w N o r m a l ’ o f M e d i c a l C a r ea n d E d u c a t i o n i n R e s o u r c e - L i m i t e d S e t t i n g s : C O V I D - 1 9 P a n d e m i c a n dB e y o n d ” a s o u r t h e m e , l e t u s c o l l a b o r a t e a n d c o n t r i b u t e i n b a t t l i n ga g a i n s t t h e C O V I D - 1 9 p a n d e m i c i n t h e 5 t h I C E o n I M E R I ,

Page 4: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 5: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

Ti

me

To

pic

08

.00

– 10

.00

Free

Pap

er

1A

Free

Pap

er

1B

Free

Pap

er

1C

Free

Pap

er

1D

10.0

0 –

10.3

0

OPE

NIN

G

MC

CHAI

RMAN

TH

E 5th

ICE

ON

IMER

I D

IREC

TOR

IMER

I FKU

I DE

AN F

KUI

10.3

0-12

.30

PLEN

ARY

LECT

URE

SER

IES

I M

oder

ator

: Pro

f. Bu

di W

iwek

o

10.3

0 –

10.5

5

PLEN

ARY

LECT

URE

1

The

role

of m

edic

al re

sear

ch in

pan

dem

ic re

spon

se a

nd re

adin

ess

Pr

of. B

amba

ng S

oem

antr

i

10.5

5-11

.20

PLEN

ARY

LECT

URE

2

The

futu

re o

f med

ical

tech

nolo

gy a

nd A

rtifi

cial

Inte

llige

nce

in th

e ne

w n

orm

al

Prof

. Gua

ng Z

hong

Yan

g

11.2

0 -

11.4

5

PLEN

ARY

LECT

URE

3

The

Impo

rtan

ce o

f Gen

omic

Big

Dat

a An

alys

is in

Pan

dem

ic R

espo

nse

Pras

hant

h N

Sur

avaj

hala

11.4

5 -

12.1

0

PLEN

ARY

LECT

URE

4

Chal

leng

es, o

ppor

tuni

ties,

and

pos

sibl

e fr

amew

orks

for c

ontin

uing

to b

uild

bio

info

rmat

ics s

oftw

are

com

mun

ities

acr

oss A

sia

Row

land

Mos

berg

en

SCIE

NTI

FIC

SCHE

DULE

M

onda

y, N

ovem

ber 9

, 202

0

Page 6: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

12.1

0 –

12.3

0 PA

NEL

DIS

CUSS

ION

12.3

0 - 1

3.00

BR

EAK

13.0

0 –

14.0

0

SYM

POSI

UM

1A

[Infe

ctio

us d

iseas

e an

d im

mun

olog

y]

Cl

inic

al M

anife

stat

ions

of C

OVI

D-1

9: F

rom

A to

Z

(Rob

ert S

into

)

a.

Typi

cal a

nd A

typi

cal M

anife

stat

ions

of

COVI

D-19

( Ad

ityo

Susi

lo )

b.

Thro

mbo

embo

li in

CO

VID-

19 In

fect

ion

(Lug

yant

i Suk

rism

an)

SYM

POSI

UM

1B

[Occ

upat

iona

l and

Env

ironm

enta

l Hea

lth]

O

ccup

atio

nal A

djus

tmen

ts D

urin

g CO

VID

-19

Pand

emic

(M

ucht

arud

din

Man

syur

)

a.

Reco

mm

enda

tions

in W

orkp

lace

Pol

icy

to

Prev

ent C

OVI

D-19

(Ast

rid B

Sul

istom

o)

b.

Wor

k fr

om h

ome:

Tip

s and

Tric

ks (D

ewi

Yuni

a Fi

tria

ni)

SYM

POSI

UM

1C

[Hum

an N

utrit

ion]

Die

t, pl

anet

, and

hea

lth: s

usta

inab

le fo

od sy

stem

fo

r pro

mot

ive

and

prev

entiv

e ca

re

(Nur

ul R

atna

Mut

u M

anik

am)

1.

Bu

ildin

g su

stai

nabl

e fo

od sy

stem

in

heal

th c

are

(Rin

a Ag

ustin

a)

2.

Hidd

en C

ost d

ari S

istem

Pan

gan

dan

Tata

G

una

Laha

n di

Indo

nesia

(R

omau

li Pa

ngga

bean

)

14.0

0-15

.00

SY

MPO

SIU

M 2

A [M

edic

al T

echn

olog

y]

U

sing

Med

ical

Tec

hnol

ogy

for C

OVI

D-1

9 Im

agin

g in

Res

ourc

e-Li

mite

d Se

ttin

g

(Muh

amm

ad N

adhi

f)

1.

Appl

icat

ion

of D

igita

l Tec

hnol

ogy

in

COVI

D-19

Pan

dem

ic

( Pra

sand

hya

Asta

giri

Yusu

f) 2.

Th

e “F

IGHT

CO

VID”

Stu

dy: U

tilizi

ng

Artif

icia

l Int

ellig

ence

to D

iagn

ose

COVI

D-19

(Eric

Dan

iel T

enda

)

SY

MPO

SIU

M 2

B [In

fect

ious

dise

ase

and

imm

unol

ogy]

The

“Red

and

Whi

te”

Vacc

ine:

Pro

vidi

ng N

atio

nal

Prev

entio

n ag

ains

t CO

VID

-19

(Bet

i Ern

awat

i)

a.

Pote

ntia

l Vac

cine

for S

ARS

CoV2

: Wha

t to

Expe

ct?

(Am

in S

oeba

ndrio

) b.

CO

VID-

19 V

acci

ne in

Indo

nesia

: Pr

elim

inar

y Re

sults

(Kus

nand

i Rus

mil)

SYM

POSI

UM

2C

[Hum

an N

utrit

ion]

Die

t, Pr

obio

tic, M

icro

biom

e, a

nd C

oron

aviru

s:

Gut

-Bra

in-L

ung-

Imm

une-

Axis

(P

rof B

adriu

l Heg

ar)

1.

Di

etar

y m

odul

atio

n of

Pro

biot

ic, I

nfec

tion

and

Covi

d-19

(Rin

a Ag

ustin

a)

2.

Mic

robi

ota,

Gut

-Bra

in-L

ung-

Imun

e-Ax

is an

d Dy

sbio

sis in

Cov

id-1

9 (P

rof M

urda

ni

Abdu

llah)

Page 7: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

Tim

e To

pic

08.0

0-09

.00

SYM

POSI

UM

3A

[Hum

an G

enet

ics]

Gen

etic

and

Dia

gnos

tic A

spec

ts o

f CO

VID

-19

Infe

ctio

n (In

a S

Tim

an)

a.

Ho

st g

enet

ic s

usce

ptib

ility

tow

ards

CO

VID-

19 In

fect

ion

(Yul

ia A

riani

) b.

Di

agno

stic

Met

hods

for C

OVI

D-19

in

Reso

urce

-Lim

ited

Sett

ing

(Viv

i Se

tiaw

aty)

SYM

POSI

UM

3B

[Infe

ctio

us d

iseas

e an

d im

mun

olog

y]

Clin

ical

Man

agem

ent a

nd O

utco

mes

of C

OVI

D-

19: S

harin

g Se

ssio

ns

(Ern

i Juw

ita N

elw

an)

a.

Cl

inic

al M

anag

emen

t of C

OVI

D-19

: Le

sson

s Lea

rned

from

Per

saha

bata

n Ho

spita

l (Er

lina

Burh

an)

b.

Pred

icto

rs a

nd O

utco

me

of S

ever

e CO

VID-

19: L

esso

ns L

earn

ed fr

om D

r. Ci

pto

Man

gunk

usum

o H

ospi

tal (

Mira

Yu

liant

i

SYM

POSI

UM

3C

[Ste

m C

ell a

nd T

issue

Eng

inee

ring]

Upd

ates

on

Stem

Cel

ls a

nd S

ecre

tom

e fo

r CO

VID

-19

(P

rof.

Ism

ail H

adiso

ebro

to D

ilogo

)

a.

MSC

vs S

ecre

tom

e fo

r CO

VID-

19 th

erap

y (P

rof.

Jean

ne A

diw

inat

a Pa

wita

n)

b.

Desig

ning

stem

cel

l EVs

for C

ovid

19

ther

apy

(Rad

iana

Dhe

way

ani A

)

09.0

0 –

10.0

0

SYM

POSI

UM

4A

[Dru

g De

velo

pmen

t]

U

pdat

es o

n CO

VID

-19

Med

icin

es

(Adi

sti D

wija

yant

i)

a.

Pote

ntia

l Ant

ivira

l Dru

g fo

r SAR

S Co

V-2:

Res

ults

from

RCT

s (Ro

bert

Si

nto)

b.

In

done

sian

trad

ition

al m

edica

tion

for

prev

entin

g CO

VID-

19 (P

rof.

Erni

Pu

rwar

ning

sih)

c.

Virt

ual S

cree

ning

on

Indo

nesia

n He

rbal

Com

poun

ds a

s CO

VID-

19

Supp

ortiv

e Th

erap

y w

ith M

olec

ular

M

odel

ing

Appr

oach

(Lin

da E

rlina

)

SYM

POSI

UM

4B

[Neu

rosc

ienc

e an

d Br

ain

Deve

lopm

ent]

COVI

D-1

9’s I

mpa

ct o

n th

e H

uman

Min

d ( K

ham

elia

Mal

ik)

a.

De

pres

sion

Prev

entio

n in

the

COVI

D-1

9 Pa

ndem

ic E

ra (M

artin

a W

iwie

) b.

Th

e Ro

le o

f Bra

in P

last

isity

in D

epre

ssio

n (N

urha

di Ib

rahi

m)

c.

Anxi

ety

as a

man

ifest

atio

n of

m

iscon

cept

ion

amid

st C

OVI

D-19

pa

ndem

ic (S

ylvi

a De

tri E

lvira

)

SYM

POSI

UM

4C

[Met

abol

ic D

isord

er, C

ardi

ovas

cula

r, an

d Ag

ing]

COVI

D-1

9, A

ging

and

Nut

ritio

n an

d D

iabe

tes

( Lus

iani

)

a.

The

Role

of N

utrig

enom

ics i

n M

anag

ing

Diab

etes

in T

he N

ew N

orm

al E

ra (

Nan

ny

N.M

Soe

tedj

o )

b.

T

he In

ter-

rela

tion

betw

een

COVI

D-19

and

Agin

g (A

gian

Jeffi

lano

Bar

inda

) c.

M

etab

olic

and

Imm

unol

ogy

Chan

ges i

n Di

abet

es P

atie

nts w

ith C

OVI

D-19

(Far

id

Kurn

iaw

an)

10.0

0 –

12.0

0 Fr

ee P

aper

2A

Fr

ee P

aper

2B

Fr

ee P

aper

2C

Fr

ee P

aper

2D

SCIE

NTI

FIC

SCHE

DULE

Tu

esda

y, N

ovem

ber 1

0, 2

020

Page 8: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

12.0

0 –

13.0

0 BR

EAK

13.0

0 –

15.0

0 PL

ENAR

Y LE

CTU

RE S

ERIE

S II

Mod

erat

or: D

iant

ha S

oem

antr

i

13.0

0 - 1

3.25

PLEN

ARY

LECT

URE

5

Revo

lutio

nizi

ng m

edic

al e

duca

tion

in re

sour

ce-li

mite

d se

ttin

g du

ring

pand

emic

Pr

of. M

adaw

a Ch

andr

atila

ke

13.2

5 –

13.5

0

PLEN

ARY

LECT

URE

6

Upd

ate

on E

xper

ienc

es w

ith th

e 1.

5 m

eter

dis

tanc

e re

stric

tion

in a

nato

my

teac

hing

due

to th

e CO

VID

-19

Regu

latio

ns

Prof

. Mar

co C

. DeR

uite

r

13.5

0 –

14.1

5 PL

ENAR

Y LE

CTU

RE 7

M

itiga

ting

the

colla

tera

l dam

age

of e

mer

genc

y CO

VID

-19

outb

reak

pol

icie

s Pr

of. D

ra. F

atm

a Le

star

i

14.1

5 –

14.4

0 PL

ENAR

Y LE

CTU

RE 8

O

utbr

eak

Polic

ies f

or C

OVI

D-1

9: L

esso

ns L

earn

ed fr

om Ja

kart

a dr

. Dw

i Okt

avia

14.4

0 –

15.0

0 PA

NEL

DIS

CUSS

ION

15.0

0 -

sele

sai

CLO

SIN

G

Page 9: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

D A Y - 1M O N D A Y , N O V 9 T H 2 0 2 0

0 8 . 0 0 - 1 0 . 0 0 A M

P O S T E R P R E S E N T A T I O N

T O P I C :R o o m 1 : H u m a n G e n e t i c , S t e m C e l l , C a n c e r

R o o m 2 : I n f e c t i o u s D i s e a s eR o o m 3 : M e t a b o l i c a n d C a r d i o v a s c u l a r

R o o m 4 : H u m a n R e p r o d u c t i o n , N e u r o s c i e n c e

P l a t f o r m : Z o o m M e e t i n g

Page 10: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 11: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 12: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

α

Page 13: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 14: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

D A Y - 2T U E S D A Y , N O V 1 0 T H 2 0 2 0

1 0 . 0 0 A M - 1 2 . 0 0 P M

P O S T E R P R E S E N T A T I O N

T O P I C :R o o m 5 : A r t i f i c i a l I n t e l l i g e n c e , M e d i c a l

T e c h n o l o g y , G e n e r a l S u r g e r yR o o m 6 : E p i d e m i o l o g y , M e d i c a l E d u c a t i o n ,

O c c u p a t i o n a l a n d H e a l t h E n v i r o n m e n tR o o m 7 : H y p o x i a a d n O x i d a t i v e S t r e s s ,

H u m a n N u t r i t i o n , S p o r t S u d i e sR o o m 8 : D r u g D e v e l o p m e n t

P l a t f o r m : Z o o m M e e t i n g

Page 15: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 16: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 17: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 18: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

β

Page 19: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D
Page 20: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

STEM CELL,HUMAN GENETIC,

CANCER

� � � � � � � � � � � � � � � � � �

�����

����� � �� � � � ���� � ������� �� � ��� � ������������ � � ���� � � � ������������

��� ��� �� � � !�" �����

���#$

%��� � �& � �� � �' ���� � � ("����� � � � ��� � (�� �� � � � ��� ����"��"����� ������" � ��

'�� �)��� �*������

����#

�� � � � �+������ ��� ������������� �������� � � �� �* �'�"���

����,

������������ � � ��� �� � � � ������"���� � ��� ��� � �� ���� � � � �� � � ����

�����-����� ����� � � � � ����� � �� ���� � �������� � �����"

��##,

.������������ �� � � � ���� � '�������� � /�!���� � '����� ���� � ��'�/' � � �

+ 0������� ��� �1�"� ����� �'����� �� � ��� �2����

��#�$

1���"� �� � ��� � �� � ��� � � �������� �� � � � ���3� ��� �� � ���� � � ���0��� � ��

���4���� ! � � � �0� � �� � � � �!��� �� � � � ���4���� ! � � � ���� �� � �� � ���� ���- � �5

� � ����

���6�

����� �2 �"�� �� ���� � � � -� � �� �7���� ���� �� �'������� �� �+�� � �'��-���� �2���

�����

��,��

.���� �� �� � � � � 1������� � 8� �� � � � ��666(�� � � � ��� � .� � ���� � � � ������

"������ �1� ���� � � � .������

��5#5

2��� � ����� � � �� � ����� � � � 1��� ���� � ��� � � � � ������ � �� � 7���� � ��� ��

/������ ������ �8��+ �������� � �� �9�0 � � � ����� �� ��

��5#�

��!�������� � � � �� ���� ���� � � ����� � �������� � � �� ������ � ����� � � � ��� ���� � �

�� �6 �� � � � �� � �� ��������� � �������� �� � � . �� �� �� ��� �������� �� �'�� ���� � �

��5��

������� �� � � � &5� � �"�� � � �� � �� � %������� � � �� �("�����"�� � /� � � � � ��!����

%�����"���� ���� ���

��5��

���� � � ����� � �-�� � 2������ � ��� ���� �������� � � � � � �� � � � ��� ��� � ' ����

������� �� � � .� �8� �� � ���"

���,$

8� �� � ������ �� � � � ���� � �� � � � ��������� � �% �����" � � �5 � �� ��� � ���(% � � �

�������"����� ��� � �'"�� � .8� �1� ���� � � � .������

���5�

����� � � ���"� � � � � ���� � �� � � � ��������� � �% �����" � � �5 � �� ��� � ���(% � � �

1� ���� ���� ����:�� �� � � � .������

Page 21: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

INFECTIOUSDISEASE

� � � � � � � � � � � � � � � � � �

�� �� ��� � �������� �� ������ � �� � ������ ������ � �� ����� ������������

�� !!

��"��� � ������� ��� ����� �� �#���� �$ �%�� �& �'��� �&��(���) � ��

������ ��� ������ � � �) �� ��� � � ��� � �) ��"� �� ���� ����

�� !*

��� � � �+ ��((��� �+ �,�( �� �-����� � � � �� ����. �,����� �� ������ � � �)

�� ��� � � ��� � �) ��"� �� ���� ���� � �����+�� ����� �&���)� �� ���(�)

�� !/

����� � �� �"��"�� � ��� �( � � � � � � � � ��0��� �� ���(�� � � ��(�

�� !�

1.�"�� � �'� ��& ���� ��� �"��� � � �� ��� ����")������(� ��(�(�

��"� �#� �� �� ���� �� �)��� �����0�� ��� ��(�� ���.� � �#��� �2��� ����� �3��(� �� �

�� *�

�/ ��)���4)"�������� � ���)���"����������� � �������������

�+ �� � �� ��"� �� �����. � �� �"�� �� ����

��*�!

&���� ��� ��� � ��0� � ��!� � �� � � ��(��� � ��� � ����)��� � ��(����( � �� � %(�� � �(��� �� ���)

�� �(� �&�5(� �� � �(� �� �� ���) ��)���� � �%�� �&��� �"�� ���� � �� ���"(�� ����+ ��� �%��"� �� �

��*�6

����� ��� ����� �, ������� � �� ��"���) ���� ���� �0��� ����(�� � �"�� ��� � �& ���� ��� ��

��/�$

&�� �� ��� �� ���0������" �#��0��� ���� �-� � ��� ��� �����

%�� ����� ���� �� ������ � �� �%��"� �� ��

��/�*

��+ �� � �� � �� �� ��� ��� ���� ��� �������� ���(� �� �%���� �)� � �

��� 6

������ � �) � ��� � ����� � � �) � &���)� � � � ����� � �� � ���"��� �+ � ������� � ��������� � �� � 1��� �+ � 7(���(�� ��� �

�����(�� � �� �3�� ���) �%��"��� �

��� �

��(���� �� ���� � � �+ ������ � �� �� �� ����+�) � �&� � ������ ��� ���� ��"���

����!

�"��� �� ��&�� ���+ �� ������� ��� ��7� � �� �� ���� �������� � �� � ������ ��

���$�

����"�(�� �8 ��� ��)���� ����� ������" � �� � ������ �� ������ � �� �������� � �& ��)�� ����� �&""�����

���!6

����(��� � ���� ��� � � � � �� � ������+ � �(� � �� � � � �� ��� � �) � �(�"��� � � �� � �� �� ��(� � "� � ���� � � � � �� � ���

"�� ����

���*$

1+��(�� ��� �� ����� ���(� �&������ ��� ��� � �� �, � ��� ��� � � � �� �9�� ���"(�

���6�

�� �� ��� � � �������� � � � ��� � ��� � �� �%��"��� � � ����� � � �) � � � �(�����) � 3(���(��� � � � 0��� � &�(� � ��"� �����)

,� � �(�

���6$

�� �� �3������)��"��� � �� ����� ������ � �� � �� �� ��� � � �& ��)���� �� ��+�0

����!

��(��� ��(� �� � � ������� ��� ���� ���� ���� ���� � �� ������ � �� � � �& ��)���� �� ��+�0

���/*

�������� �� �,������ �� ������ � � �) � �� ���+�� � �� ���� ���� � �� ��� � � �.�. �3(�(����(�� �'��� � �%��"� �� �

�//*

�(���� ( � �3����� �� ��+� ������ � �� ���+�4 ������ �� �0���

1���� � �) �&�������� �&���� �� �� �������� ��� �3���") � �& ����

�"���

���/�

��� ���� ��� �3�� �� ��5(�� �� � ������ �,� � �(� �&������ ����� � ��

������ ��� ��� ���) ������ � � �) ��( � �� ������ � �� � �� � ����� �+ ���� �����

Page 22: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

METABOLIC ANDCARDIOVASCULAR

� � � � � � � � � � � � � � � � � �

�����

����� � � ��� ��� � ��� ���� � �������� � � � ��� � �������� �� � �� � ������ �� � ��� ����� � �� ����� � ����� � �������

���������� ����� � ������� � � �� ������ � ��!"��

�#$�%

������ �� � � &��� � '��� ��"( �� � �$ � �)� � � � � ���� � *!��"� ������� � +��� � ,����� � ���� � ����� � �� � �� ��� ���

������ ���� ������!�� � ��� ��� � ��� �������

�#$�%

������ � �"��� �� � � �������� � �� �� ���� � +��� � � ��"� � � � ��!��� �� � � ���������� � �������

�� � � �� �-���� ����� �)�� � ���� � �α � ���� ��� �� �.�� �"�� �� ���!� ��� � ��.� �

�#/��

,�� � �� ����� � � ������ �� � *����� � � � �� � ��� � �!��� �� �� � �)� � � ���� � 0"�� � ��"�� � �� � +"� � � ���

1��� ���� �

�#/�%

���!���� � ����� � ���� � ������� � ��� �� � ��� � '����� � �" �� � ����� �� � ����"�� � � � � � �� � �� � � � � � � �����

+���� �)�� � �,�!� �� ��������� ���� � � �"�

�#/��

��)��!���� � �����)���"�� �������� ������� �)� ����� � �� ������������ � ���� � *�"�� � �+��( � ���� �

.� ����"������� �������� � �� ���

�#�#2

��!��� �� � ���� ���� �� ���� �-�"��� �� ����!������ �-��� � �� �+�� ����� �3������ ���� �+��� ��� �� �����

�##��

-������� � ��� � � '�!)����� � ��� �� ����� � � ,�!� � � � �������� � ��� � � �"� � ��� ���� � 4�� � 0�� � � �� � &�����

�������

�##�%

��� �� � '�� ��� ������ �,���(���� � �� �-�)�� � �������� � ���!� ��� �4)�� �&�!���� �� ���� �+����� �� �*����

�##�/

,�� � �"� � � 3��"�� � � &������ � � � ���� � ���������� � � '��" � �� � +�� �� ����� � �&4�� � '+ � � ���

, �� ���� ��� �-�"��� � �,�- � � '���� � ������� �� �*����� � �� ���� �*��� ���� �*�"�� � �� � '����� ��� �+"� �

�!"��� ��

�##��

���� ��� �� � � '� ������� � ��(�� � ��� � ��5 � ��)��� � ������ � �)���� � '�� ������ � �� � ��"�� � ����

*�����

�##%/

�"����� �+��"��� � '� ������� �+��!��� � �� � �* �*� ��"����� �!� �!��� � ���� ����"���� ���� � � � � ,�!�

� ��������� ���� � � �"�

�##%�

,�� � '�!��� � � +������ � ���� ��� � � � -������� � ��� � � ��� � ���" �� �� � �)� � � �� � ��� ����� � ���� � ��������

��� � � �"�

�##62

'�!�� �� � '� ������� � ���( ��� � ��"�� �� � �� � ����� � ��� � ���!����� � �� �)�� � � � ,�!� � � � ��������

��� � � �"� ���� �����

�##%$

��)� ����� ���� ����� ����� ������ � ������� �*��"�� ���� "��� �� � �� �7��� ����� �,�!� �� ��������� ���� � � �"�

�� � '����� �� � �� �*������� �� �+�)���

�#//%

�4���+'*4. � 4� � ��,��4 '� � *0.�+4�� � � &4�� � '+ � � �.� � '�4�� '. �� � ��4.- � 041.- � ��1 , � '. � +1+�

�.� �1+��. ��+��

�#2��

+� �,'4. ���,7��. � �184�0,� ��41., ��.� ��8�� � �3� � '. ���1,� ��04��+�'� � '.��+�,'4. ���,'�.,*

�, �-�.�+� �&4*�',� ��+4� ��+ �8�.�41

�##�6

,�� � '�!��� � � &����� � ������� � � � -������� � ��� � � ��"�� � � � ���� �� � ��� ���� �� � � � ,�!� � � � ��������

��� � � �"� ���� �����

Page 23: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

HUMANREPRODUCTION;NEUROSCIENCE

� � � � � � � � � � � � � � � � � �

�����

��� �� � � �� �� �� � ���� ������ � �� ����� � ��

�����

�� ���� ������ �� � � � � ���� ��� � � � � ������

�����

����� ��� ����� � �� ! � � �"#� � �$� � �� � � �"$ � ���� � � ���#!�� �%� � ���� ��#& �� �� � �� ���� ��� � � � � �' ���

�����

(� � � � ���� � �� � )� � "�#� � ��! � � *#�! � � � %# � � � �� � (� � �� � ��� �� � �+", � �� & ���� � -���

�� ���� � � � �� �+ �� ��� � � ���#� �! �.� �� � �� /#�� � �, �(�� � ������ �0#�� �

�����

������ � ����%� � � � ������ � �� �� � � �� � � �� � � �� �� �,���� � (#�� � � � � � ����� � �� � ����%� � � 0�� � � 1���� �

������

�����

(��!� � �� �(� � � �� � �� �* !� �� � �� ��

�����

" � �! �)#�� �)� � 0#� � � � �� �!#� � �� � ,�#� � � ���� �0�)��� � ��#� �! � .� �� � �� /#�� � ( ���� � ��

,�� ! ��� �+��& �*! ��

����2

(� � � � � � �( � �3#� � � � � �0��� � �� �( ���� �4�� ���1 � � �,� � �� � ) � � � ����� �

�����

3#� � � � � � 5 � �� � � � ��1 � ( ���� � 4�� � (�� � ��� � � "�#� �� � +�!��) ��� � " � �0)#���� � ,� � �� � ) � � �

���� �

�����

� ��� � � � � � �,#�� �� �� � �! � ������� �� ��� �,#�� �� �.� ����� ������� �� � �� ���� ��� ��� ���� ���

�����

,��� � ���� ��� ������ �'�� � �.���� ��#� ��� ��61�� � �� �(�����! � �� �7&�

�����

,006��,��� �*,��6+0 �6* ���(+�00�6" �,"� �,"8���9 � �" �:"��+-+,�:,��

�����,5 �0�:��"�0

�����

.� ��!� � ! � � � ������� � �� � ���� ��!�� �� � , � !� � � � .� �� � � � ��� ���� � 4�� � � ��� �� � �

(� � ���� �(��!� �! �0�� �� �4�� �:�! �� � ��� ���%��� ���� � � #� � �� ��61�� � �� ���

�����

*! �� �,�� ! ��� �4�� �,���� �� �� �* � �� ��� �0�! �� ��� ������

(����� �' ��� � �� �7&�

Page 24: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

ARTIFICIALINTELLIGENCE;

MEDICALTECHNOLOGY;

GENERAL SURGERY

� � � � � � � � � � � � � � � � � �

27752A Compar i son o f Ocu la r T rauma Scores and Ped ia t r i c Ocu la r T rauma Scores i n Ped ia t r i c C losed and Open G lobeIn ju r i es27757Spontaneous Retrobulbar Hemorrhage in a Previously Healthy Infant27771Sa t i s fac t i on and Qua l i t y o f L i f e o f M ic ro t i a Pa t ien ts Fo l l ow ing Recons t ruc t i ve Surge ry Us ing Naga ta Techn ique28056Cumulative Fluid Balance and Urine Albumin-Creatinin Ratio are able to Predict Capillary Leakage in Major Abdominal Surgery:Prospective Observational Study28060Sta r t i ng Endoscopy Sp ine Surge ry : Ka r iad i ’ s Hosp i ta l Exper ience28539Use of Furosemide in Traumatic Hemothorax With Low Central Venous Pressure Targeted to Preserve Renal Function28543Ear l y 12hours Con t inuous K idney Rep lacemen t Therapy (CKRT) A f te r Ao r ta Va lve Rep lacemen t Pa t ien t ReducedAcu te K idney In ju ry28575Optical Coherence Tomography Angiography and Swept-Source Optical Coherence Tomography Findings in Acute PosteriorMultifocal Placoid Pigment Epitheliopathy: A Case Report28720Sc le ra l con tac t l enses i n pos t t raumat i zed eye , repo r t o f two cases28818The Ro le o f G lycodeoxycho l i c Ac id (GDOC) to Induce Acu te Panc rea t i t i s i n Macaca nemes t r i na28827Whole Innovation Solution (WInS) Thinking in the New Normal Era28833Case Repor t : Keys tone t ype IV Per fo ra to r F lap fo r Pa te l l a r De fec t Recons t ruc t i on i n Pso r ia t i c Pa t ien t28838C losu re o f Thoraco -Ompha lopagus Con jo ined Tw ins De fec t a f te r Separa t i on Us ing Loca l Pe r fo ra to r F laps du r ingCOVID-19 Pandemic28850The Feas ib i l i t y o f Super Low Pressu re P resca le F i lm as A S imp le Feedback Sys tem fo r Lea rn ing The Sk i l l o fIn tuba t ion28609Ef f i c i ency o f A r t i f i c i a l I n te l l i gence – Based Compute r P rog ram in De tec t i on o f Pu lmonary Tubercu los i s : ASys temat i c Rev iew28779Ar t i f i c i a l I n te l l i gence D iagnos is o f COVID-19 Us ing Ches t X - rays : Sys temat i c Rev iew and Me ta -ana lys i s28974CERVICAL CANCER SCREENING USING DEEP LEARNING CLASSIF ICATION MODEL28965Delayed Treatment in Penile Fracture with Rupture Urethra After Multiple Urethral Catheterization: A Case Report28963Periurethral Condyloma: A Case Report28976The Deve lopmen t o f an Andro id -based Lung Sounds Auscu l ta t i on C lass i f i ca t i on us ing Convo lu t i ona l Neura lNe twork Mode l28953To ta l I n t ravenous Anes thes ia i n Ch i l d ren w i th Cerebe l l opon t ine Ang le Tumor Who Undergone M ic rosu rg i ca lCran io tomy w i th In t raOpera t i ve Mon i to r i ng

Page 25: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

EPIDEMIOLOGY;MEDICAL EDUCATION;

OCCUPATIONAL &ENVIRONMENTAL

HEALTH

� � � � � � � � � � � � � � � � � �

27791Compar i son o f CDC Char t and Indones ia Na t iona l Growth Char t t o asses He igh t o f Nab i re and Jaka r ta e lemen ta ryschoo l ch i l d ren , as we l l as the i n f l uenc ing fac to rs27798Fac to rs Tha t A f fec ted Qua l i t y o f L i f e i n Ch i l d ren Wi th O I Ho l l i s t i ca l l y28572Ready o r No t to Face the New Norma l fo r Po ly techn ic S tuden t?28771Case Repor t : Cha l l enge as Phys i c ian to D iagnose Ped ia t r i c Pa t ien t W i th La ryngopharyngea l Re f lux28776Ef fec t o f Sh i f t Work on The Change o f t he I schemic Ecg Pro f i l e among S tee l I ndus t r y Worke rs28794Med ica l S tuden ts ’ Pe rspec t i ves and Exper iences o f On l i ne Learn ing Dur ing Cov id -19 Pandemic : A Qua l i t a t i veS tudy28796The Compar i son o f M ice ’ s H ind L imb Decompos i t i on S tage tha t i s P rev ious l y P rese rved w i th Advanced F ixa t i veSo lu t i on o f E thano l -G lyce r in and 4% Forma ldehyde28845Menta l Emot iona l D is t ress Among A i r Nav iga t i on Worke rs a t Supad io In te rna t i ona l A i rpo r t s28851Team Coord ina t i on T ra in ing : A Way to E leva te Techn ica l and Non-Techn ica l Sk i l l i n Emergency Med ica l Team28855Preva lence and R isk Fac to rs o f Ocu la r Su r face D isease Symptoms Among Moto rcyc le Tax i D r i ve rs i n Indones ia : ACross -Sec t iona l S tudy28857New Adap ta t i on o f Neurosu rg i ca l P rac t i ce and Res idency P rog ram Dur ing Cov id -19 Pandemic i n Na t iona l Re fe r ra lHosp i ta l , Jaka r ta , I ndones ia28866Rena l Func t i on Ana lys i s o f C rane Opera to r Worke r i n The Con ta ine r Te rm ina l and Re la ted Fac to rs28798Po tency o f Sod ium B ica rbona te i n neu t ra l i z i ng fo rma l in and make decompo t i t i on o f p rese rved cadaver p rocessge t t i ng fas te r : Sys temat i c Rev iew28949A Re tu rn to Work P rog ramme a t A Sh i f t Work Secur i t y O f f i ce r w i th Hyper thy ro id i sm Graves’ D isease : A CaseRepor t28808ASSOCIATION BETWEEN BENZENE EXPOSURE AND SPONTANEOUS ABORTION IN OIL AND GAS WORKER28979Preva lence and R isk Fac to rs o f V i sua l Impa i rmen t i n Indones ian E lde r l y Popu la t i on : A Mu l t i cen te r S tudy28969Ref rac t i ve E r ro r o f E lemen ta ry Schoo l S tuden ts i n Pen ja r ingan D is t r i c t , No r th Jaka r ta28950Rena l Func t i on Ana lys i s O f Crane Opera to r Worke r In The Con ta ine r Te rm ina l And Re la ted Fac to rs27750Sa t i s fac t i on and Qua l i t y o f L i f e o f M ic ro t i a Pa t ien ts Fo l l ow ing Recons t ruc t i ve Surge ry Us ing Naga ta Techn ique28985The Ro le o f S i sman t i k to Mon i to r Mosqu i to La rvae a t Schoo l t o Reduce the R isk o f Sp read ing the Dengue Vec to r

Page 26: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

HYPOXIA & OXIDATIVESTRESS;

HUMAN NUTRITION;SPORT STUDIES

� � � � � � � � � � � � � � � � � �

27793Adduc to r Po l l i c i s Musc le Th ickness , Energy In take , A lbumin Serum, and Neu t roph i l -Lymphocy te Ra t io asPred ic to rs o f Mor ta l i t y i n Cr i t i ca l l y I l l Pa t i en ts27856Admin i s t ra t i on o f Ea r l y Norep inephr ine and Fu rosemide in the T rea tmen t o f Sep t i c Shock Pa t ien ts27927Va l id i t y and Re l i ab i l i t y t es t o f Fou r Me te r Ga i t Speed a t S i x Me te rs T rack i n Indones ian Hea l thy Adu l t (Mongo lo id )27959Agreemen t Tes t Be tween The S ix M inu tes Wa lk ing Tes t And Four Me te r Ga i t Speed27963Ef fec t o f Exp i ra t i on Musc le Exe rc i se Us ing Pos i t i ve Exp i ra to ry P ressu re i n Chron ic Obs t ruc t i ve Pu lmonary D isease27966The Four Me te r Ga i t Speed Cu t -O f f Po in t i n Indones ian Popu la t i on28043H igh Cap i l l a ry Leak Index i s Assoc ia ted w i th Inc reased R isk o f ICU-Re la ted Mor ta l i t y A f te r Ma jo r Abdomina lSurge ry : P rospec t i ve Observa t i ona l S tudy28064The E f fec ts o f a 12 -week Ha tha Yoga In te rven t ion on Handgr ip S t reng th , F lex ib i l i t y , Ba lance , and Ga i t Speed inOverwe igh t and Obese Peop le : A Randomized Con t ro l l ed T r ia l28544Does Lac tobac i l l us supp lemen ta t i on improve g l ycemic con t ro l i n pa t i en ts w i th Type I I D iabe tes Me l l i t us?28852Ef fec t o f Ac id i f i ca t i on on Ox ida t i ve S t ress S ta tus o f Pe r iphe ra l B lood Mononuc lea r Ce l l s and I t s Impac t on Ce l lV iab i l i t y28854Re la t i onsh ip be tween se rum e lec t ro l y tes ( K ) and u r ina ry e lec t ro l y tes w i th c rea t i n ine i n ch ron ic k idney d i sease28865The E f fec ts o f Synb io t i c Supp lemen ta t i on on L ip id P ro f i l es i n Adu l t : a Me ta -Ana lys i s o f Randomized Con t ro l T r i a l28954Atopob ios i s and Dysb ios i s i n Ocu la r D iseases : I s Feca l M ic rob io ta T ransp lan t and Prob io t i cs A P romis ingSo lu t i on?28977Nut r i t i ona l Management o f Tubercu los i s Pa t ien t w i th Re feed ing Syndrome: A Case Repor t28980The Hydra t i on S ta tus o f Co l l eg ia te A th le tes du r ing Exerc i se : E f f i cacy o f Good Hydra t i on P rac t i ce Educa t ion us inge - f l ye r

Page 27: 0 + % * + & - - % 6! # ! #$ ! $ ' )H 2 I 2 D

DRUG DEVELOPMENT

� � � � � � � � � � � � � � � � � �

28057Ef fec ts o f Sa lung (Psycho t r i a Ma layana) Leaves Ex t rac t on the G lucose Leve l i n Induced Type 2 D iabe t i c Ra t28061Ef fec ts o f Cen te l l a as ia t i ca and Aca lypha ind i ca L . Ex t rac t on Superox ide D ismutase Leve ls i n L i ve r o f AgedSprague-Dawley Ra t28062Ef fec t o f Cen te l l a as ia t i ca and Aca lypha ind i ca L . on the G lu ta th ione Leve ls i n the L i ve r o f t he O ld Sprague-DawleyRa t28549The E thano l Ex t rac t o f Pomegrana te (Pun ica Grana tum) Exocarp i n Inc reas ing the Express ion o f Caspase 3 onDSS- Induced M ice Cryp t Ce l l s28557Ef fec t i veness o f Ora l Gabapen t in 600 mg as P reempt i ve Ana lges ia to Reduce Morph ine Requ i remen ts i n Pa t ien tsUndergo ing Non-Obs te t r i c Lower Abdomina l Su rge ry28558In S i l i co , I n V i t ro , and In V ivo S tud ies o f Soybean Ex t rac t w i th Ta rge ted Lunas in (E t -Lun ) as An t i -B reas t Cancer 28581An t i A the rogen ic E f fec t o f Soybean (G lyc ine Max) Seed Ju i ce and G ingger (Z ing ibe r o f f i c i na le ) Rh izoma onD iabe t i c Ra t28757Study In S i l i co The Po ten t i a l O f Neem Leaves As An An t i -COVID 1928759In S i l i co S tudy on Compound Ac t i v i t i es o f Empr i t G inger Rh izomes Ex t rac t t owards Inh ib i t o ry Ac t i v i t yAce ty l cho l i nes te rase , β -Tubu l i n and the Ac t i va t i on o f Ca lc ium Channe ls as An the lm in t i c28760Po tency o f Bu tened io i c ac id o f Soursop Leaves Wate r Ex t rac t as DPP4 inh ib i t o r28055Ef fec t o f Cen te l l a as ia t i ca and Aca lypha ind i ca L . on the G lu ta th ione Leve ls i n the L i ve r o f t he O ld Sprague-DawleyRa t28759In S i l i co S tudy on Compound Ac t i v i t i es o f Empr i t G inger Rh izomes Ex t rac t t owards Inh ib i t o ry Ac t i v i t yAce ty l cho l i nes te rase , Î ² -Tubu l i n and the Ac t i va t i on o f Ca lc ium Channe ls as An the lm in t i c28978The E f fec t O f Red Be te l Leaves (P ipe r Croca tum) 96% E thano l Ex t rac t On The Reduc t ion O f B lood G lucose In m ice(Mus Muscu lus ) I n A l l oxan Induc t i on